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PRIMARY CARE
Referral Patterns for Genetic Counseling for
Hereditary Breast and Ovarian Cancer Syndromes
[40D]
Leah Hong, MD
Henry Ford Health System, Detroit, MI
Jacquelyn Roberson, and Roopina Sangha, MD
INTRODUCTION: BRCA 1 or 2 mutation carriers have a 45–85%
risk of developing breast cancer and a 39–46% risk of developing
ovarian cancer by age 70.
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METHODS: A retrospective electronic chart review was conducted to
identify women who were referred to the Henry Ford Health System
Genetics department for counseling, as new consultations between 01/
01/16 to 12/31/16 with a diagnosis that contained “breast”, “ovarian”,
“ovary”, or “adnexa”. Women with a known cancer diagnosis were
excluded. Information on age, race, if genetic testing was collected
including if testing was offered and/or accepted, results of genetic
testing, insurance type and referring provider specialty.
RESULTS: A total of 184 women with an average age of 46 years was
included. 93 (50.5%) referrals were from obstetricians/gynecologists,
44 (23.9%) from internal medicine, 23 (12.5%) from family medicine,
13 (7.1%) from surgery, and 11 (6%) self-referrals. Of the 20 women
who were not offered genetic testing, 5 (25%) had federal assisted
insurance. The reasons documented for lack of genetic testing was due
to inability to meet Medicare criteria or lack of clinical indication. 164
women were offered genetic testing, of which 147 accepted. Of the
147/164 (89.6%) a total of 14/147 (9.5%) women identified with
positive hereditary breast and ovarian cancer mutation. 10/147 (6.8%)
women were noted to have a variant mutation.
CONCLUSION/IMPLICATIONS: Patients at high risk for hereditary cancer syndromes should be provided with a referral for genetic
counseling based on extensive review of family history on both sides,
including the ages of onset of cancer.

a friend. Although none of the materials highlighted LARC methods,
half of all participants chose a LARC method.
CONCLUSION: Women were satisfied with all approaches to postpartum contraception counseling in this study, which on average took only
seven minutes. Our PtDA offer a low-tech solution that women find
helpful. Further research is needed to determine its impact in the long-term.
Financial Disclosure: The authors did not report any potential conflicts of
interest.

California State Law (SB-999) and Implementation:
Dispensing a Year-long Supply of Prescription Birth
Control [2E]
Gelareh Nikpour, MD
UCLA Department of Obstetrics and Gynecology, Los Angeles, CA
Antoinette Allen, BA, Sally Rafie, PharmD, BCPS, Radhika Rible, MD,
and Angela Chen, MD, MPH
INTRODUCTION: Access to birth control is the cornerstone to
preventing unplanned pregnancies. In California, women qualifying for state-funded reproductive insurance get yearlong supplies of
contraception from participating dispensaries. A 2011 study found
a 30% odds reduction in unplanned pregnancies when women
received yearlong supplies of birth control as compared to one- or
three-month supplies (Foster, 2011). Subsequently, in 2016, California Senate Bill-999 was passed, designating that women could
receive yearlong supplies of birth control from pharmacists while
requiring insurance companies to fund these prescriptions.Using
secret shopper methods, we will conduct a cross-sectional survey of
California pharmacies to inquire whether they are able to comply
with SB-999.

Financial Disclosure: The authors did not report any potential conflicts of
interest.

METHODS: 19,693 pharmacies met our inclusion criteria: commercial retail pharmacies in California. 13,660 were excluded for revoked/
cancelled licenses or because they were affiliated with managed care or
publicly funded networks. Based on our pilot study, for a power of
80%, 600 pharmacies were randomly selected from the remaining
6033. Using a secret shopper technique, these pharmacies are called
and asked whether they can dispense yearlong supplies of prescription
birth control to customers.

4:30 PM–5:30 PM
CONTRACEPTION/FAMILY PLANNING
Effectiveness of a Patient Decision Aid in Postpartum
Contraceptive Counseling [1E]

RESULTS: We are currently collecting date. Based on preliminary
review of 200 pharmacies called, with approximately 80% completed
calls, 44% of pharmacists have not heard of SB-999. The top two
obstacles to dispensing yearlong supplies of birth control quoted were
insurance coverage (37%) and company policy (16%).
CONCLUSION: Implementation of new laws take time and require
institutional accountability. In revealing obstacles to accessing yearlong supplies of birth control, we aim to expedite implementation of
SB-999.

Sandolsam Cha, MD
Albert Einstein College of Medicine/Montefiore Medical Center,
New York City, NY
Erika Levi, MD, MPH, Molly Findley, DO, MPH, MS, Wendy Leung, MD,
Miriam Tarrash, BS, and Nerys Benfield, MD, MPH
INTRODUCTION: Effective postpartum contraceptive counseling
helps patients meet their reproductive life goals. Patient decision aids
(PtDA) can facilitate counseling but the optimal structure and medium
for a PtDA is unknown.
METHODS: On postpartum day 1, women who had not received
a postplacental LARC were randomized to: 1) a paper-based PtDA that
featured contraceptive options for side-by-side comparison, 2) standard
contraception brochure, or 3) website with comparison of contraceptive options. All patients received counseling utilizing their assigned
tool. The concordance between a patient’s decision and their values
(“decision quality”) and the extent to which she is clear about her
values and feels informed (“decision-making process quality”), were
evaluated using validated surveys.
RESULTS: 126 patients were enrolled. The average age of participants was 28.9, half were Latina, 69% had public insurance, 42% were
primiparous, and 60% had a vaginal delivery. There were no statistical
differences among the groups except for counseling time (6.4 min for
PtDA, 6.6 min for the website, and 4.9 min for the standard brochure,
p50.0152). The primary outcomes of “decision quality” and “decisionmaking process quality” were not statistically different. Regardless of
the material, women found them helpful and would recommend to
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Immediate Postpartum LARC Placement May
Decrease the Risk of Short-Interval Pregnancy [3E]
Stephanie Higgins, MD
University of Connecticut Health Center, Farmington, CT
Christopher Morosky, MD, and Amy Nelson, MD
INTRODUCTION: Short interval pregnancies are associated with an
increased incidence of preterm birth, low birth weight, and small for
gestational age infants. LARC devices have been shown to be safe and
effective in helping women achieve an optimal inter-pregnancy
interval, however those studies did not evaluate LARC placed in the
immediate postpartum time period.
METHODS: This is a retrospective cohort study of clinic patients who
delivered at Hartford Hospital and requested immediate postpartum
LARC. LARC devices were supplied by periodic shipments from the
Ryan program. Near the end of shipment periods, there were often
insufficient devices to meet demand. This led to a pseudo-random
intervention in which some patients received their requested LARC
device immediately postpartum and others were given a temporary
method and asked to follow-up for outpatient LARC placement. The
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